Xantphos

CAT:
804-HY-Y0091
Size:
25 g
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Xantphos - image 1

Xantphos

  • Description:

    Xantphos (9,9-Dimethyl-4,5-bis (diphenylphosphino) xanthene) is a bisphosphine ligand. Xantphos coordinates to metals in either cis or trans chelation mode. Xantphos acts as a key ligand in palladium or platinum catalyzed reactions. Xantphos can be used in the construction of heterocyclic compounds in organic synthesis[1][2][3].
  • Product Name Alternative:

    9,9-Dimethyl-4,5-bis (diphenylphosphino) xanthene
  • UNSPSC:

    12352200
  • Hazard Statement:

    H315, H319, H335
  • Target:

    Biochemical Assay Reagents
  • Type:

    Biochemical Assay Reagents
  • Related Pathways:

    Others
  • Field of Research:

    Others
  • Assay Protocol:

    https://www.medchemexpress.com/xantphos.html
  • Purity:

    99.93
  • Solubility:

    DMSO : < 1 mg/mL (ultrasonic; warming; heat to 60°C) |Ethanol : 1 mg/mL (ultrasonic; warming; heat to 60°C)
  • Smiles:

    CC1 (C) C2=C (C (P (C3=CC=CC=C3) C4=CC=CC=C4) =CC=C2) OC5=C1C=CC=C5P (C6=CC=CC=C6) C7=CC=CC=C7
  • Molecular Formula:

    C39H32OP2
  • Molecular Weight:

    578.62
  • Precautions:

    H315, H319, H335
  • References & Citations:

    [1]Manley PJ, et al. A new synthesis of naphthyridinones and quinolinones: palladium-catalyzed amidation of o-carbonyl-substituted aryl halides. Org Lett. 2004 Jul 8;6 (14) :2433-5.|[2]Petöcz G, et al. Xantphos as cis-and trans-chelating ligand in square-planar platinum (II) complexes. Hydroformylation of styrene with platinum–xantphos–tin (II) chloride system. Journal of organometallic chemistry, 2004, 689 (7) : 1188-1193. |[3]Gao GY, et al. General synthesis of meso-amidoporphyrins via palladium-catalyzed amidation. Org Lett. 2004 May 27;6 (11) :1837-40.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, protect from light, stored under nitrogen)
  • Scientific Category:

    Biochemical Assay Reagents
  • Clinical Information:

    No Development Reported
  • CAS Number:

    161265-03-8